Universal DX | Solution
Universal Diagnostics is a biomedicine start-up focused on the development of leading edge technologies in metabolomics, genetics and bioinformatics, with the mission to develop a blood test for early detection.
solution, cancer, biomedicine, Universal Diagnostics, Universal DX, early detection, technologies, analysis of metabolites
page,page-id-15548,page-template,page-template-full_width,page-template-full_width-php,ajax_fade,page_not_loaded,,wpb-js-composer js-comp-ver-4.2.3,vc_responsive


UDX unique and disruptive Colorectal Cancer & Adenoma Test.

Our first product will be a simple, non-invasive, accurate and inexpensive blood-based
screening test to detect early stage colorectal cancer and adenoma, allowing early detection
and cancer prevention.


The Technology

Combining biotechnology and big data.



Cancer changes the metabolism of human body, which manifests itself through the appearance and increase of differentiated small molecules (<600 Da), so called biomarkers. Metabolic profiling can give an instantaneous snapshot of the physiology of that cell. UDX has identified and quantified a proprietary panel of biomarkers that allows to differentiate cancer and adenoma patients from healthy individuals.



Machine learning techniques allow computers to model the world without being explicitly programmed by a previous knowledge, and change their state with new data sets. UDX has developed a machine learning algorithm able to decode millions of data points generated, in order to identify the most relevant biomarkers and perform accurate predictions about the health condition of a patient.

Product Development

UDX is currently completing the first product: the Colorectal Cancer Test


Utilizamos cookies propias y de terceros para mejorar tu experiencia.
Si sigues navegando, consideramos que aceptas nuestra política de cookies. Más información.

Aviso de cookies